Peter Arul Prakasam

Peter Arul Prakasam

Active Director Director DIN 07584881
DIN 07584881 First appointment Apr 2019 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2019
Shareholding value •••• Premium profile

About Peter Arul Prakasam

Data last updated:

Peter Arul Prakasam is a Director at Genometohealth Private Limited (since 2019). The company operates in Healthcare. Genometohealth Private Limited reported revenue of ₹28.1 Lakh (FY 2024).

DIN 07584881
Primary Designation Director
Industry Healthcare
First Appointment 12 Apr 2019
Oldest Company Age 7 yrs
Largest company Genometohealth Private Limited · ₹28.1 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Genometohealth Private Limited U85100KA2019PTC123426
Director12 Apr 20192019₹28.1 Lakh (FY 2024)Active

Board colleagues of Peter Arul Prakasam

NameDINCompanyDesignation
Arunmozhi Mouriya08420682Genometohealth Private LimitedDirector

Directorship timeline

Open interactive timeline →
Genometohealth Private Limited
Premium access

Shareholding and investment profile for Peter Arul Prakasam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Peter Arul Prakasam

Peter Arul Prakasam currently holds 1 directorship: Genometohealth Private Limited (Director, since 12 Apr 2019, revenue ₹28.1 Lakh (FY 2024)).

Peter Arul Prakasam was first appointed on 12 Apr 2019 as Director at Genometohealth Private Limited.

The current boards of Peter Arul Prakasam's companies include Arunmozhi Mouriya (Genometohealth Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available